Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Nanus

Showing results (51-60 of 168) with videos related to

Pageof 17
Sort By:
Cancer Causes & Control : CCC|October 25, 2023
Prostate-specific antigen testing rates in high-risk populations: results from the All of Us Research ProgramFaith Morley, Hari S Iyer, Rulla M Tamimi, et al.
Cancer Cell|January 30, 2004
Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTENMakoto Sumitomo, Akira Iwase, Rong Zheng, et al.
Oncogenesis|March 25, 2020
Membrane metalloendopeptidase suppresses prostate carcinogenesis by attenuating effects of gastrin-releasing peptide on stem/progenitor cellsChieh-Yang Cheng, Zongxiang Zhou, Meredith Stone, et al.
Clinical Genitourinary Cancer|May 30, 2006
Clinical utility of radiolabeled monoclonal antibodies in prostate cancerKevin A David, Matthew I Milowsky, Lale Kostakoglu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Neutral endopeptidase protein expression and prognosis in localized prostate cancerIman Osman, Herman Yee, Samir S Taneja, et al.
Frontiers in Oncology|October 23, 2012
Isolation and characterization of circulating tumor cells in prostate cancerElan Diamond, Guang Yu Lee, Naveed H Akhtar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor modelSue Ellen Touma, Jonathan S Goldberg, Paul Moench, et al.
Plos One|April 2, 2015
Analyses of the transcriptome and metabolome demonstrate that HIF1α mediates altered tumor metabolism in clear cell renal cell carcinomaDenise R Minton, Leiping Fu, Qiuying Chen, et al.
Neoplasia (New York, N.Y.)|June 5, 2025
Deletion of the transcription factor ATF4 in a model of clear cell renal cell carcinomaYuling Chi, Shireen Chikara, Eduardo Mere Del Aguila, et al.
The Journal of Urology|November 12, 2003
Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigenDavid M Nanus, Matthew I Milowsky, Lale Kostakoglu, et al.
Pageof 17

Showing results (51-60 of 168) with videos related to

Sort By:
Pageof 17
Cancer Causes & Control : CCC|October 25, 2023
Prostate-specific antigen testing rates in high-risk populations: results from the All of Us Research ProgramFaith Morley, Hari S Iyer, Rulla M Tamimi, et al.
Cancer Cell|January 30, 2004
Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTENMakoto Sumitomo, Akira Iwase, Rong Zheng, et al.
Oncogenesis|March 25, 2020
Membrane metalloendopeptidase suppresses prostate carcinogenesis by attenuating effects of gastrin-releasing peptide on stem/progenitor cellsChieh-Yang Cheng, Zongxiang Zhou, Meredith Stone, et al.
Clinical Genitourinary Cancer|May 30, 2006
Clinical utility of radiolabeled monoclonal antibodies in prostate cancerKevin A David, Matthew I Milowsky, Lale Kostakoglu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Neutral endopeptidase protein expression and prognosis in localized prostate cancerIman Osman, Herman Yee, Samir S Taneja, et al.
Frontiers in Oncology|October 23, 2012
Isolation and characterization of circulating tumor cells in prostate cancerElan Diamond, Guang Yu Lee, Naveed H Akhtar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor modelSue Ellen Touma, Jonathan S Goldberg, Paul Moench, et al.
Plos One|April 2, 2015
Analyses of the transcriptome and metabolome demonstrate that HIF1α mediates altered tumor metabolism in clear cell renal cell carcinomaDenise R Minton, Leiping Fu, Qiuying Chen, et al.
Neoplasia (New York, N.Y.)|June 5, 2025
Deletion of the transcription factor ATF4 in a model of clear cell renal cell carcinomaYuling Chi, Shireen Chikara, Eduardo Mere Del Aguila, et al.
The Journal of Urology|November 12, 2003
Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigenDavid M Nanus, Matthew I Milowsky, Lale Kostakoglu, et al.
Pageof 17